Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence

Journal of Neuroscience

Volumn 34, Issue 8, 2014, Pages 2822-2831

  Ceccarini, Jenny ^a,b   Hompes, Titia ^c   Verhaeghen, Anne ^c   Casteels, Cindy ^a,b   Peuskens, Hendrik ^c,d   Bormans, Guy ^e   Claes, Stephan ^c   Van Laere, Koen ^a,b,e  

^a DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^b KU Leuven   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d Psychiatrische Kliniek Broeders Alexianen   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Abstinence; Acute alcohol effect; Alcoholism; Cannabinoid CB1 receptor; Chronic alcohol effect; PET

Indexed keywords

CANNABINOID 1 RECEPTOR; DIAGNOSTIC AGENT; MK 9470; MK-9470; PYRIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ABSTINENCE; ACUTE ALCOHOL EFFECT; ACUTE DISEASE; ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; BINGE DRINKING; BRAIN MAPPING; CHRONIC ALCOHOL EFFECT; CHRONIC DISEASE; COHORT ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRINKING BEHAVIOR; HUMAN; IMAGE PROCESSING; MALE; METABOLISM; MIDDLE AGED; PET; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGICAL ASPECT; SCINTISCANNING; YOUNG ADULT;

ABSTINENCE; ACUTE ALCOHOL EFFECT; ALCOHOLISM; CANNABINOID CB1 RECEPTOR; CHRONIC ALCOHOL EFFECT; PET;

ACUTE DISEASE; ADULT; ALCOHOL DRINKING; ALCOHOLISM; BINGE DRINKING; BRAIN MAPPING; CHRONIC DISEASE; COHORT STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, CANNABINOID, CB1; TEMPERANCE; YOUNG ADULT;

EID: 84894062511     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0849-13.2014     Document Type: Article

References (65)

1. APA (1994) Diagnostic and statistical manual of mental disorders (DSMIV). Washington, DC: American Psychiatric Association.
2. Basavarajappa BS, Hungund BL (1999a) Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. J Neurochem 72: 522-528. CrossRef Medline
3. Basavarajappa BS, Hungund BL (1999b) Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res 815: 89-97. CrossRef Medline
4. Basavarajappa BS, Cooper TB, Hungund BL (1998) Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res 793:212-218. CrossRef Medline
5. Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2000) Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta 1535:78-86. CrossRef Medline
6. Basavarajappa BS, Ninan I, Arancio O (2008) Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J Neurochem 107:1001-1013. CrossRef Medline
7. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218. CrossRef
8. Burns HD, Van Laere K, Sanabria-Bohórquez S, Hamill TG, Bormans G, Eng WS, Gibson R, Ryan C, Connolly B, Patel S, Krause S, Vanko A, Van Hecken A, Dupont P, De Lepeleire I, Rothenberg P, Stoch SA, Cote J, Hagmann WK, Jewell JP, et al. (2007) [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A 104:9800-9805. CrossRef Medline
9. Caillé S, Alvarez-Jaimes L, Polis I, Stouffer DG, Parsons LH (2007) Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci 27: 3695-3702. CrossRef Medline
10. Casteels C, Koole M, Celen S, Bormans G, Van Laere K (2012) Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain. Eur J Nucl Med Mol Imaging 39:1467-1477. CrossRef Medline
11. Ceccarini J, Casteels C, Koole M, Bormans G, Van Laere K (2013a) Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study. Eur J Nucl Med Mol Imaging 40:1582-1594. CrossRef Medline
12. Ceccarini J, De Hert M, Van Winkel R, Peuskens J, Bormans G, Kranaster L, Enning F, Koethe D, Leweke FM, Van Laere K (2013b) Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia. Neuroimage 79:304-312. CrossRef Medline
13. Ceccarini J, Kuepper R, Dieter K, van Os J, Henquet C, Van Laere K (2013c) [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addict Biol. Advance online publications. Retrieved Dec. 27, 2013. doi:10.1111/adb.12116. CrossRef
14. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM (2007) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27:791-795. CrossRef Medline
15. Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R (2008) Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology 198:449-460. CrossRef Medline
16. Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MM, Gessa L (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring s P rats. Psychopharmacology 159:181-187. CrossRef Medline
17. Economidou D, Mattioli L, Cifani C, Perfumi M, Massi M, Cuomo V, Trabace L, Ciccocioppo R (2006) Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanolseeking behaviour in rats. Psychopharmacology 183:394-403. CrossRef Medline
18. Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481-1489. CrossRef Medline
19. First MB, Gibbon M, Spitzer RL, Williams JBW (2001) User Guide for the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P W/PSY SCREEN). New York: Biometrics Research.
20. George DT, Herion DW, Jones CL, Phillips MJ, Hersh J, Hill D, Heilig M, Ramchandani VA, Geyer C, Spero DE, Singley ED, O'Malley SS, Bishai R, Rawlings RR, Kunos G (2010) Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatmentseeking heavy alcohol drinkers. Psychopharmacology 208:37-44. CrossRef Medline
21. Gérard N, Pieters G, Goffin K, Bormans G, Van Laere K (2011) Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa. Biol Psychiatry 70:777-784. CrossRef Medline
22. Gomez R, Behar KL, Watzl J, Weinzimer SA, Gulanski B, Sanacora G, Koretski J, Guidone E, Jiang L, Petrakis IL, Pittman B, Krystal JH, Mason GF (2012) Intravenous ethanol infusion decreases human cortical gamma-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biol Psychiatry 71:239-246. CrossRef Medline
23. Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA (2002) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and m RNA levels. Drug Alcohol Depend 66:77-84. CrossRef Medline
24. Grant BF (1997) Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol 58:464-473. Medline
25. Hill MN, Carrier EJ, Ho WS, Shi L, Patel S, Gorzalka BB, Hillard CJ (2008) Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus 18:221-226. CrossRef Medline
26. Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS (2010) Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 30:14980-14986. CrossRef Medline
27. Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA, Innis RB (2012) Reversible and regionally selective downregulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers. Mol Psychiatry 17:642-649. CrossRef Medline
28. Hirvonen J, Zanotti-Fregonara P, Umhau JC, George DT, Rallis-Frutos D, Lyoo CH, Li CT, Hines CS, Sun H, Terry GE, Morse C, Zoghbi SS, Pike VW, Innis RB, Heilig M (2013) Reduced cannabinoid CB(1) receptor binding in alcohol dependence measured with positron emission tomography. Mol Psychiatry 18:916-921. CrossRef Medline
29. Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C (2003) Cannabinoid CB1 receptor knock-out mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 84:698-704. CrossRef Medline
30. Katona I, Freund TF (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14:923-930. CrossRef Medline
31. Koob GF (2008) A role for brain stress systems in addiction. Neuron 59:11-34. CrossRef Medline
32. Little HJ, Croft AP, O'Callaghan MJ, Brooks SP, Wang G, Shaw SG (2008) Selective increases in regional brain glucocorticoid: a novel effect of chronic alcohol. Neuroscience 156:1017-1027. CrossRef Medline
33. McLaughlin RJ, Hill MN, Dang SS, Wainwright SR, Galea LA, Hillard CJ, Gorzalka BB (2013) Upregulation of CB(1) receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. Behav Brain Res 237:333-337. CrossRef Medline
34. Mitrirattanakul S, López-Valdés HE, Liang J, Matsuka Y, Mackie K, Faull KF, Spigelman I (2007) Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence. Alcohol Clin Exp Res 31:855-867. CrossRef Medline
35. Neumeister A, Normandin MD, Murrough JW, Henry S, Bailey CR, Luckenbaugh DA, Tuit K, Zheng MQ, Galatzer-Levy IR, Sinha R, Carson RE, Potenza MN, Huang Y (2012) Positron emission tomography shows elevated cannabinoid CB (1) receptor binding in men with alcohol dependence. Alcohol Clin Exp Res 36:2104-2109. CrossRef Medline
36. O'Connor S, Morzorati S, Christian J, Li TK (1998) Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res 22:202-210. CrossRef Medline
37. Ortiz S, Oliva JM, Pérez-Rial S, Palomo T, Manzanares J (2004) Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 39:88-92. CrossRef Medline
38. Pava MJ, Woodward JJ (2012) A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol 46:185-204. CrossRef Medline
39. Pava MJ, Blake EM, Green ST, Mizroch BJ, Mulholland PJ, Woodward JJ (2012) Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology 219:137-147. CrossRef Medline
40. Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M (2005) Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology 183:368-377. CrossRef Medline
41. Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L, Alfano B, Brunetti A, Baron JC, Salvatore M (2004) Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 45:192-201. Medline
42. Rademacher DJ, Hillard CJ (2007) Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Prog Neuropsychopharmacol Biol Psychiatry 31:633-641. CrossRef Medline
43. Riegel AC, Lupica CR (2004) Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 24:11070-11078. CrossRef Medline
44. de Rodríguez Fonseca F, Cebeira M, Ramos JA, Martín M, Fernández-Ruiz JJ (1994) Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci 54:159-170. CrossRef Medline
45. Romero J, García L, Fernández-Ruiz JJ, Cebeira M, Ramos JA (1995) Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol Biochem Behav 51:731-737. CrossRef Medline
46. Rubio M, Fernández-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA (2008) CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. Neuropharmacology 54:976-988. CrossRef Medline
47. Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, Fernandez-Ruiz J, Ali C (2011) Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. PLo S One 6:e23690. CrossRef Medline
48. Rupp TL, Acebo C, Van Reen E, Carskadon MA (2007) Effects of a moderate evening alcohol dose. I: sleepiness. Alcohol Clin Exp Res 31:1358-1364. CrossRef Medline
49. 18)F]MK-9470 in human brain. Eur J Nucl Med Mol Imaging 37:920-933. CrossRef Medline
50. Skinner HA, Sheu WJ (1982) Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol 43:1157-1170. Medline
51. Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF (2008) Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J Clin Psychopharmacol 28:317-324. CrossRef Medline
52. Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND (2005) Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 164:206-213. CrossRef Medline
53. Thie JA, Hubner KF, Isidoro FP, Smith GT (2007) Aweight index for the standardized uptake value in 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography. Mol Imaging Biol 9:91-98. CrossRef Medline
54. Van Laere K, Nuttin B, Gabriels L, Dupont P, Rasmussen S, Greenberg BD, Cosyns P (2006) Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 47:740-747. Medline
55. Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon J, Bormans G (2008) Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. Neuroimage 39:1533-1541. CrossRef Medline
56. Van Laere K, Casteels C, Dhollander I, Goffin K, Grachev I, Bormans G, Vandenberghe W (2010) Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo. J Nucl Med 51:1413-1417. CrossRef Medline
57. Van Laere K, Casteels C, Lunskens S, Goffin K, Grachev ID, Bormans G, Vandenberghe W (2012) Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo. Neurobiol Aging 33:620. e1-8. CrossRef Medline
58. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299-315. CrossRef Medline
59. Vinod KY, Yalamanchili R, Xie S, Cooper TB, Hungund BL (2006) Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem Int 49:619-625. CrossRef Medline
60. Vinod KY, Maccioni P, Garcia-Gutierrez MS, Femenia T, Xie S, Carai MA, Manzanares J, Cooper TB, Hungund BL, Colombo G (2012) Innatedifferenceinthe endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring s P rats. Addict Biol 17:62-75. CrossRef Medline
61. Volkow ND, Wang GJ, Fowler JS, Tomasi D (2012) Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 52:321-336. CrossRef Medline
62. Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 100:1393-1398. CrossRef Medline
63. Webster LR, Johnson FK, Stauffer J, Setnik B, Ciric S (2011) Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users. Drugs R D 11:259-275. CrossRef Medline
64. Zoethout RW, van Gerven JM, Dumont GJ, Paltansing S, van Burgel ND, van der Linden M, Dahan A, Cohen AF, Schoemaker RC (2008) A comparative study of two methods for attaining constant alcohol levels. Br J Clin Pharmacol 66:674-681. CrossRef Medline
65. Zoethout RW, Schoemaker RC, Zuurman L, van Pelt H, Dahan A, Cohen AF, van Gerven JM (2009) Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers. Br J Clin Pharmacol 68:524-534. CrossRef Medline